Literature DB >> 25846704

Generation of Helios reporter mice and an evaluation of the suppressive capacity of Helios(+) regulatory T cells in vitro.

Kazunari Sugita1,2, Sho Hanakawa1, Tetsuya Honda1, Gen Kondoh3, Yoshiki Miyachi1, Kenji Kabashima1, Takashi Nomura1.   

Abstract

Helios is a member of the Ikaros transcription factor family and has been reported to be a marker of thymus-derived regulatory T cells (Treg). Helios is an intracellular protein, however, and hence cannot be used as a marker to separate living Tregs. To solve this problem, we generated Helios reporter mice in which Helios+ cells selectively express Venus, a variant of green fluorescent protein. Most of the Tregs in the thymus expressed Helios, whereas its expression was varied in peripheral lymphoid organs. The Helios+ Treg-population was superior in ability to suppress both antigen-specific and TCR-stimulated T cell responses. We also showed that Helios+ Tregs inhibited the cytokine production by T cells more efficiently than Helios- Tregs. We conclude that Helios reporter mouse strain is a useful tool to study function of Helios and that Helios+ Tregs represent the highly suppressive population.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Foxp3; Helios; Treg; contact hypersensitivity; lymph node

Mesh:

Substances:

Year:  2015        PMID: 25846704     DOI: 10.1111/exd.12711

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  15 in total

1.  Helios+ and Helios- Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires.

Authors:  Angela M Thornton; Jinghua Lu; Patricia E Korty; Yong Chan Kim; Craig Martens; Peter D Sun; Ethan M Shevach
Journal:  Eur J Immunol       Date:  2019-01-15       Impact factor: 5.532

Review 2.  Helios: still behind the clouds.

Authors:  Angela M Thornton; Ethan M Shevach
Journal:  Immunology       Date:  2019-10-13       Impact factor: 7.397

3.  Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells.

Authors:  Amara Seng; Kelsey L Krausz; Dong Pei; Devin C Koestler; Ryan T Fischer; Thomas M Yankee; Mary A Markiewicz
Journal:  Blood Adv       Date:  2020-04-14

Review 4.  Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function.

Authors:  Kaitlin A Read; Devin M Jones; Aharon G Freud; Kenneth J Oestreich
Journal:  Immunol Rev       Date:  2020-12-17       Impact factor: 12.988

Review 5.  The Ikaros family of zinc-finger proteins.

Authors:  Yingzhi Fan; Duo Lu
Journal:  Acta Pharm Sin B       Date:  2016-06-24       Impact factor: 11.413

6.  Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model.

Authors:  Kirsten K Dietze; Simone Schimmer; Freya Kretzmer; Junzhong Wang; Yong Lin; Xuan Huang; Weimin Wu; Baoju Wang; Mengji Lu; Ulf Dittmer; Dongliang Yang; Jia Liu
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

7.  The Role of the Ikaros Family of Transcription Factors in Regulatory T cell Development and Function.

Authors:  Amara Seng; Thomas M Yankee
Journal:  J Clin Cell Immunol       Date:  2017-03-22

8.  Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells.

Authors:  Stephanie Downs-Canner; Sara Berkey; Greg M Delgoffe; Robert P Edwards; Tyler Curiel; Kunle Odunsi; David L Bartlett; Nataša Obermajer
Journal:  Nat Commun       Date:  2017-03-14       Impact factor: 14.919

Review 9.  Coexpression of Helios in Foxp3+ Regulatory T Cells and Its Role in Human Disease.

Authors:  Wen-Qing Yu; Ning-Fei Ji; Cheng-Jing Gu; Yan-Li Wang; Mao Huang; Ming-Shun Zhang
Journal:  Dis Markers       Date:  2021-06-22       Impact factor: 3.434

10.  Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.

Authors:  Eyad Elkord; May Abd Al Samid; Belal Chaudhary
Journal:  Oncotarget       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.